QuickLinks -- Click here to rapidly navigate through this documentStockholder Agreement • May 29th, 2008 • Bristol Myers Squibb Co • Pharmaceutical preparations • Delaware
STOCKHOLDER AGREEMENT (this "Agreement"), dated as of May 28, 2008, by and among Bristol-Myers Squibb Company, a Delaware corporation ("Parent"), KB Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Sub"), and the individuals and other parties listed on Schedule A hereto (each a "Stockholder").
AGREEMENT AND PLAN OF MERGER among BRISTOL-MYERS SQUIBB COMPANY, KB ACQUISITION CORP. and KOSAN BIOSCIENCES INCORPORATED dated as of May 28, 2008Agreement and Plan of Merger • May 29th, 2008 • Bristol Myers Squibb Co • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER dated as of May 28, 2008 (this "Agreement"), by and among Bristol-Myers Squibb Company, a Delaware corporation ("Parent"), KB Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Sub"), and Kosan Biosciences Incorporated, a Delaware corporation (the "Company").
STANDSTILL AGREEMENTStandstill Agreement • May 29th, 2008 • Bristol Myers Squibb Co • Pharmaceutical preparations
This Standstill Agreement (this "Agreement") is entered into as of May 15, 2008 in connection with the Mutual Nondisclosure Agreement (the "Confidentiality Agreement") dated as of April 9, 2008 between BRISTOL-MYERS SQUIBB COMPANY ("BMS"), and KOSAN BIOSCIENCES INCORPORATED (the "Company").
